Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Shirali Agarwal"'
Autor:
Michelle Hudspeth, Shahram Mori, David Nachbaur, José Antonio Perez-Simon, Friedrich Stölzel, Marcie Riches, Wendy Wu, Peixin Zhang, Shirali Agarwal, Ibrahim Yakoub-Agha
Publikováno v:
Haematologica, Vol 108, Iss 4 (2022)
Acute graft-versus-host disease (aGvHD) is a life-threatening complication typically occurring within 100 days after allogeneic hematopoietic cell transplantation (allo-HCT). This hypothesis-generating, phase II, prospective, open-label, randomized s
Externí odkaz:
https://doaj.org/article/9469cc3c425e42909a82b326aff8f36b
Autor:
Mohamed L. Sorror, Shirali Agarwal, Megan Othus, Ylinne Lynch, Jennifer E. Nyland, Mary‐Elizabeth Percival, Pamela S. Becker, Frederick R. Appelbaum, Elihu H. Estey
Publikováno v:
Cancer Medicine, Vol 9, Iss 18, Pp 6515-6523 (2020)
Abstract Background Low‐intensity regimens have been increasingly used to treat older patients with acute myeloid leukemia (AML). Recent studies, however, suggest older patients can tolerate and potentially benefit from intensive chemotherapeutic r
Externí odkaz:
https://doaj.org/article/a55df821182943a69f00be2393140f0f
Autor:
Luke Maese, Mignon L. Loh, Mi Rim Choi, Tong Lin, Etsuko Aoki, Shirali Agarwal, Xiaotian Wu, Robert Iannone, Jeffrey A. Silverman, Lewis B. Silverman, Elizabeth A. Raetz, Rachel E. Rau
Publikováno v:
Blood. 140:8969-8970
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d5f78b25f75dcc48072fb2b0f312b85e
https://doi.org/10.1182/blood-2022-160192
https://doi.org/10.1182/blood-2022-160192
Autor:
Michelle, Hudspeth, Shahram, Mori, David, Nachbaur, José Antonio, Perez-Simon, Friedrich, Stölzel, Marcie, Riches, Wendy, Wu, Peixin, Zhang, Shirali, Agarwal, Ibrahim, Yakoub-Agha
Publikováno v:
Haematologica.
Acute graft-versus-host disease (aGvHD) is a life-threatening complication typically occurring within 100 days after allogeneic hematopoietic cell transplantation (allo-HCT). This hypothesisgenerating, phase 2, prospective, open-label, randomized stu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d9290cb7c6a443babbf5a4a053e87a1d
https://pubmed.ncbi.nlm.nih.gov/36519326
https://pubmed.ncbi.nlm.nih.gov/36519326
Publikováno v:
Bone Marrow Transplantation. 56:492-504
Allogenic hematopoietic stem cell transplant is the only curative option for symptomatic sickle cell disease (SCD). HLA haploidentical related donor transplants are associated with high graft failure rates. We conceptualized a novel protocol (APOLLO
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::723a4ecdc4560a5590c8df08e07bdd9a
https://doi.org/10.1038/s41409-020-01054-3
https://doi.org/10.1038/s41409-020-01054-3
Autor:
Ylinne Lynch, Elihu H. Estey, Jennifer E. Nyland, Pamela S. Becker, Megan Othus, Frederick R. Appelbaum, Mary Elizabeth Percival, Shirali Agarwal, Mohamed L. Sorror
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 9, Iss 18, Pp 6515-6523 (2020)
Cancer Medicine, Vol 9, Iss 18, Pp 6515-6523 (2020)
Background Low‐intensity regimens have been increasingly used to treat older patients with acute myeloid leukemia (AML). Recent studies, however, suggest older patients can tolerate and potentially benefit from intensive chemotherapeutic regimens.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b8689a0707b02d72ba92917b3520b45
https://doi.org/10.1002/cam4.3311
https://doi.org/10.1002/cam4.3311
Autor:
Luke Devon Maese, Mignon L. Loh, L. Mi Rim Choi, Tong Lin, Etsuko Aoki, Michelle Zanette, Shirali Agarwal, Jeffrey Alan Silverman, Lewis B. Silverman, Elizabeth A. Raetz, Rachel E. Rau
Publikováno v:
Journal of Clinical Oncology. 40:7001-7001
7001 Background: The inability to receive L-asparaginase (ASNase) therapy due to hypersensitivity is associated with inferior outcomes in patients with ALL or LBL. JZP458, a recombinant Erwinia-derived ASNase from a Pseudomonas fluorescens expression
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::41b379cb06bfa09c6713d8274f12d257
https://doi.org/10.1200/jco.2022.40.16_suppl.7001
https://doi.org/10.1200/jco.2022.40.16_suppl.7001
Publikováno v:
Supportive Care Strategies ISBN: 9783319590134
The advent of allogeneic hematopoietic cell transplantation (allo-HCT) brought potential cures to a large number of malignant and non-malignant hematological disorders. Unfortunately, the curative benefits associated with allo-HCT are eclipsed by an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d1bcfc31f4253804ff27fc1236ac15ce
https://doi.org/10.1007/978-3-319-59014-1_5
https://doi.org/10.1007/978-3-319-59014-1_5
Autor:
Lewis B. Silverman, Jeffrey A. Silverman, Mignon L. Loh, Michelle Zanette, Elizabeth A. Raetz, Rachel E. Rau, Tong Lin, Luke Maese, Mi Rim Choi, Etsuko Aoki, Shirali Agarwal
Publikováno v:
Blood. 138:2307-2307
Background: In patients with ALL, inability to receive L-asparaginase therapy due to hypersensitivity is associated with higher relapse risk (Gupta S, et al. J Clin Oncol. 2020). JZP458 is a recombinant Erwinia asparaginase derived from a novel Pseud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0f267d477a3fb9e68503ec39124a48cc
https://doi.org/10.1182/blood-2021-147023
https://doi.org/10.1182/blood-2021-147023